FACTS ABOUT BIOVICA AND DIVITUM™
Biovica is a bio-diagnostic company focused on providing improved diagnostics, predictive data and monitoring of cancer patient under treatment. Biovica has developed DiviTum™, a highly sensitive assay for measuring cell proliferation. Since one of the most fundamental characteristics of cancer is uncontrolled and increased cell growth, DiviTum™ enables valuable prediction capability and monitoring of compounds regulating cell proliferation and the cell cycle. Biovica is ISO 13485 certified for Quality Management Systems and DiviTum™ is CE labeled and MPA registered.
Anders Rylander, CEO
Direct +46 (0) 18 44 44 835
Göran Brorsson,Chairman of the Board Biovica
Mobile phone: +46 705 11 78 60